- Report
- April 2025
- 244 Pages
Global
From €4987EUR$5,450USD£4,333GBP
- Report
- April 2025
- 262 Pages
Global
From €4987EUR$5,450USD£4,333GBP
- Report
- April 2025
- 193 Pages
Global
From €5125EUR$5,600USD£4,453GBP
- Report
- April 2025
- 268 Pages
Global
From €4987EUR$5,450USD£4,333GBP
- Report
- April 2025
- 193 Pages
Global
From €4987EUR$5,450USD£4,333GBP
- Report
- April 2025
- 292 Pages
Global
From €5125EUR$5,600USD£4,453GBP
- Report
- April 2025
- 188 Pages
Global
From €5125EUR$5,600USD£4,453GBP
- Report
- April 2025
- 213 Pages
Global
From €4987EUR$5,450USD£4,333GBP
- Report
- April 2025
- 198 Pages
Global
From €4987EUR$5,450USD£4,333GBP
- Report
- February 2025
- 334 Pages
Global
From €5125EUR$5,600USD£4,453GBP
- Report
- March 2025
- 294 Pages
Global
From €4109EUR$4,490USD£3,570GBP
- Report
- March 2025
- 250 Pages
Global
From €4109EUR$4,490USD£3,570GBP
- Report
- March 2025
- 175 Pages
Global
From €4109EUR$4,490USD£3,570GBP
- Report
- March 2025
- 200 Pages
Global
From €4109EUR$4,490USD£3,570GBP
- Report
- March 2025
- 250 Pages
Global
From €4109EUR$4,490USD£3,570GBP
- Report
- March 2025
- 400 Pages
Global
From €4109EUR$4,490USD£3,570GBP
- Report
- March 2025
- 250 Pages
Global
From €4109EUR$4,490USD£3,570GBP
- Report
- March 2025
- 175 Pages
Global
From €4109EUR$4,490USD£3,570GBP
- Report
- March 2025
- 250 Pages
Global
From €4109EUR$4,490USD£3,570GBP
- Report
- March 2025
- 250 Pages
Global
From €4109EUR$4,490USD£3,570GBP

The biopharmaceuticals market is a sector of the pharmaceutical industry that focuses on the development and production of drugs derived from biological sources. These drugs are typically produced using recombinant DNA technology, which involves the manipulation of genetic material to create proteins and other molecules with therapeutic properties. Biopharmaceuticals are used to treat a wide range of diseases, including cancer, HIV/AIDS, and autoimmune disorders.
Biopharmaceuticals are typically more expensive to produce than traditional pharmaceuticals, but they offer a number of advantages, such as improved efficacy and fewer side effects. They are also more targeted, meaning they can be used to treat specific conditions more effectively.
Some of the major companies in the biopharmaceuticals market include Amgen, Biogen, Celgene, Gilead Sciences, and Novartis. These companies are involved in the development and production of a wide range of biopharmaceuticals, including monoclonal antibodies, vaccines, and gene therapies. Show Less Read more